Santiago Arroyo

Director/Board Member presso H. LUNDBECK A/S

Patrimonio netto: 971 100 $ in data 31/03/2024

64 anni

100 relazioni

Health Technology

Consumer Services

Health Services

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
Michael Skynner	M	55	BICYCLE THERAPEUTICS PLC PFIZER, INC.	11 anni
Kevin Lee	M	55	BICYCLE THERAPEUTICS PLC PFIZER, INC.	12 anni
Ganesh Venkataraman Kaundinya	M	57	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	4 anni
Amir Faridmoayer	M	-	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	-
Jose-Carlos Gutiérrez-Ramos	M	61	BICYCLE THERAPEUTICS PLC PFIZER, INC.	9 anni
Dominique Sirena	M	-	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	-
Alistair Milnes	M	50	BICYCLE THERAPEUTICS PLC	3 anni
Lars Søren Rasmussen	M	65	H. LUNDBECK A/S	11 anni
Jim Smith	M	64	PFIZER, INC.	10 anni
Stephen Sands	M	67	BICYCLE THERAPEUTICS PLC	-
Jeremy Levin	M	70	H. LUNDBECK A/S	7 anni
Jeffrey Berkowitz	M	58	H. LUNDBECK A/S	6 anni
Gregory Winter	M	73	BICYCLE THERAPEUTICS PLC	15 anni
Lene Skole-Sørensen	F	65	H. LUNDBECK A/S	9 anni
Helen Hobbs	M	71	PFIZER, INC.	13 anni
Joseph Echevarria	M	66	PFIZER, INC.	9 anni
Janice Bourque	F	67	BICYCLE THERAPEUTICS PLC	5 anni
Travis Thompson	M	-	BICYCLE THERAPEUTICS PLC	6 anni
Dorothea Wenzel	M	55	H. LUNDBECK A/S	3 anni
Lars Erik Holmqvist	M	64	H. LUNDBECK A/S	9 anni
Richard Kender	M	68	BICYCLE THERAPEUTICS PLC	5 anni
Shantanu Narayen	M	60	PFIZER, INC.	11 anni
Lars Bang	M	61	H. LUNDBECK A/S	36 anni
Charl van Zyl	M	57	H. LUNDBECK A/S	1 anni
Lasse Skibsbye	M	41	H. LUNDBECK A/S	2 anni
Denis Patrick	M	-	PFIZER, INC.	14 anni
Zafar Qadir	M	-	BICYCLE THERAPEUTICS PLC	4 anni
Sonya Weigle	F	-	MARINUS PHARMACEUTICALS, INC.	3 anni
Thomas Edward Gibbs	M	53	H. LUNDBECK A/S	1 anni
Tarek Samad	M	-	H. LUNDBECK A/S	3 anni
Steve Danehy	M	-	PFIZER, INC.	12 anni
Dorte Clausen	F	40	H. LUNDBECK A/S	2 anni
Hossein Armandi	M	62	H. LUNDBECK A/S	2 anni
Camilla Andersson	F	52	H. LUNDBECK A/S	2 anni
Nicholas Keen	M	56	BICYCLE THERAPEUTICS PLC	7 anni
Thomas Mikkel Mortensen	M	-	H. LUNDBECK A/S	-
Georges Gemayel	M	64	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	2 anni
Keld Flintholm Jørgensen	M	53	H. LUNDBECK A/S	5 anni
Monique Schiersing	M	-	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	-
David Borah	M	-	BICYCLE THERAPEUTICS PLC	3 anni
James Sutcliffe	M	68	BICYCLE THERAPEUTICS PLC	1 anni
Pierre Legault	M	63	BICYCLE THERAPEUTICS PLC	5 anni
Palle Holm Olesen	M	-	H. LUNDBECK A/S	-
Graziano Seghezzi	M	55	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	-
Nigel Crockett	M	59	BICYCLE THERAPEUTICS PLC	5 anni
Kush Parmar	M	42	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	2 anni
Johan Luthman	M	65	H. LUNDBECK A/S	5 anni
Alethia Young	F	45	BICYCLE THERAPEUTICS PLC	1 anni
Jakob Riis	M	58	H. LUNDBECK A/S	1 anni
Juliane Lenzner	F	-	H. LUNDBECK A/S	-
Ivan Cheung	M	47	EISAI CO., LTD.	19 anni
Jörg Hornstein	M	47	H. LUNDBECK A/S	2 anni
Mira Chaurushiya	M	-	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	-
Philippe Dro	M	61	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	2 anni
Jennifer Perry	F	-	BICYCLE THERAPEUTICS PLC	-

Mostra altro

Grafico relazionale

Relazione in diverse aziende

Relazioni precedenti

Nome	Sesso	Età	Società collegate	Collaborazione
Jeffrey Kindler	M	68	PFIZER, INC.	8 anni
William Steere	M	87	PFIZER, INC.	28 anni
Lee Kalowski	M	43	BICYCLE THERAPEUTICS PLC	6 anni
Deborah Dunsire	M	61	H. LUNDBECK A/S	5 anni
Amy Schulman	F	63	PFIZER, INC.	6 anni
George A. Lorch	M	82	PFIZER, INC.	15 anni
Michael Dougherty	M	66	MARINUS PHARMACEUTICALS, INC.	5 anni
Yi Ning Zhao	M	53	PFIZER, INC.	8 anni
Elise Hauge	F	57	H. LUNDBECK A/S	4 anni
John Mascotte	M	84	PFIZER, INC.	4 anni
Shinji Hatta	M	-	EISAI CO., LTD.	4 anni
Marc Tessier-Lavigne	M	64	PFIZER, INC.	4 anni
Jacob Tolstrup	M	52	H. LUNDBECK A/S	25 anni
Anders Götzsche	M	56	H. LUNDBECK A/S	15 anni
Everett Cunningham	M	57	PFIZER, INC.	9 anni
Robert Landry	M	60	PFIZER, INC.	4 anni
Olivier Brandicourt	M	68	PFIZER, INC.	13 anni
Nicole Vitullo	F	66	MARINUS PHARMACEUTICALS, INC.	17 anni
Veronica Jordan	M	73	BICYCLE THERAPEUTICS PLC	5 anni
Michael Brown	M	82	PFIZER, INC.	16 anni
M. Anthony Burns	M	81	PFIZER, INC.	25 anni
William Herbert Gray	M	82	PFIZER, INC.	13 anni
Robert N. Burt	M	86	PFIZER, INC.	11 anni
Alan Mendelsohn	M	62	PFIZER, INC.	2 anni
David Peritt	M	60	PFIZER, INC.	1 anni
Paulash Mohsen	M	-	PFIZER, INC.	14 anni
Premal Patel	M	54	PFIZER, INC.	2 anni
Margaret Marshall	M	67	PFIZER, INC.	8 anni
Venkat Reddy	M	-	PFIZER, INC.	2 anni
Reina Benabou	M	60	PFIZER, INC.	4 anni
Bhooshitha B. de Silva	M	49	PFIZER, INC.	11 anni
Tanya de Foras	F	53	PFIZER, INC.	10 anni
Hong I. Wan	M	-	PFIZER, INC.	5 anni
Carl Morris	M	54	PFIZER, INC.	5 anni
Soma Gupta	F	-	PFIZER, INC.	6 anni
Adrian Woolfson	M	60	PFIZER, INC.	3 anni
William S. Korinek	M	-	PFIZER, INC.	9 anni
Baiyong Li	M	56	PFIZER, INC.	12 anni
Margaret McLoughlin	M	61	PFIZER, INC.	5 anni
Santhosh Palani	M	41	PFIZER, INC.	3 anni
Valerie Start	M	64	PFIZER, INC.	3 anni
Karen Boykin-Towns	F	59	PFIZER, INC.	4 anni
Nat Ricciardi	M	75	PFIZER, INC.	7 anni
Martine George	M	76	PFIZER, INC.	5 anni
Iain Kilty	M	-	PFIZER, INC.	6 anni

Statistiche

Paese	Relazioni	% del totale
Stati Uniti	48	48.00%
Danimarca	25	25.00%
Regno Unito	19	19.00%
Svizzera	9	9.00%
Giappone	2	2.00%

Età delle relazioni

Attive

Scorse

Uomo

Donna

Amministratori

Dirigenti

Provenienza delle relazioni